Lifespin launches therapeutic drug monitoring laboratory software
Summary
Lifespin has launched its Therapeutic Drug Monitoring software for anti-infectives, meaning laboratories will be able to use the algorithm to gain measurements of antibiotics in the blood of patients. Lifespin’s product utilises nuclear magnetic resonance (NMR) to test for commonly used antibiotics, including Ceftazidim, Cefuroxim, and Ceftriaxon. Around 1.27 million people die each year worldwide due to antimicrobial resistance, with the disease burden greatest in low-income and middle-income countries. According to GlobalData’s pipeline data, six antibiotic/antivirus therapeutic drug monitoring products are currently in active development. Lifespin CEO Dr Ali Tinazli said: “Responding to market demands for enhanced antibiotic stewardship, we’ve made this groundbreaking technology accessible globally through our cloud-based system.